These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21358362)

  • 21. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
    Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
    Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
    Zou X; Dong F; Zhang S; Tian R; Sui R
    Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
    Solano JM; Pulido JS; Salomao DR
    Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
    Lobato L
    J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His.
    Schweitzer K; Ehmann D; Garcia R; Alport E
    Can J Ophthalmol; 2009 Jun; 44(3):317-9. PubMed ID: 19491989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amyloidosis of the vitreous body. Possibilities of diagnosis].
    Soltau JB; Seiberth V; Knorz MC; Liesenhoff H
    Fortschr Ophthalmol; 1991; 88(4):408-10. PubMed ID: 1786932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular Manifestations of Familial Transthyretin Amyloidosis.
    Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
    Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
    Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
    Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation.
    Ciulla TA; Tolentino F; Morrow JF; Dryja TP
    Surv Ophthalmol; 1995; 40(3):197-206. PubMed ID: 8599155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary glaucoma in patients with familial amyloidotic polyneuropathy.
    Kimura A; Ando E; Fukushima M; Koga T; Hirata A; Arimura K; Ando Y; Negi A; Tanihara H
    Arch Ophthalmol; 2003 Mar; 121(3):351-6. PubMed ID: 12617705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
    Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y
    J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation.
    Kawaji T; Ando Y; Hara R; Tanihara H
    Ophthalmology; 2010 Mar; 117(3):552-5. PubMed ID: 20045573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary macular hole formation after vitrectomy.
    Lee SH; Park KH; Kim JH; Heo JW; Yu HG; Yu YS; Chung H
    Retina; 2010; 30(7):1072-7. PubMed ID: 20168267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Outcome after vitrectomy in rhegmatogenous retinal detachment and dense vitreous opacities].
    Hoerauf H; Roider J; Herboth T; Hager A; Laqua H
    Klin Monbl Augenheilkd; 1997 Dec; 211(6):369-74. PubMed ID: 9498187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitrectomy for endogenous fungal endophthalmitis.
    Shen X; Xu G
    Ocul Immunol Inflamm; 2009; 17(3):148-52. PubMed ID: 19585356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
    Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
    Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No ocular involvement in familial amyloidotic polyneuropathy ATTR V30M domino liver recipients.
    Beirão M; Matos E; Beirão I; Pinho-Costa P; Torres P
    Transpl Int; 2012 Jun; 25(6):646-51. PubMed ID: 22443165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical case of the month: non-familial vitreous amyloidosis].
    Tek A; Rakic JM
    Rev Med Liege; 2013; 68(7-8):396-8. PubMed ID: 24053097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients.
    Oguchi K; Takei Y; Ikeda S
    Amyloid; 2006 Jun; 13(2):99-107. PubMed ID: 16911964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.